Study of childhood cancer survivors shows reduction in radiation therapy leads to decline of second cancers
Changes in childhood cancer treatment, including the reduced use of radiation therapy, has reduced the risk for second cancer in survivors.
The new grant supports the opening of the St. Jude gene therapy protocol for X-linked SCID at the University of California, San Francisco (UCSF) Benioff Children's Hospital San Francisco.
Researchers craft a new approach for mining genomic data for rare genetic variations that may play a role in disease risk.
Screening for all children newly diagnosed with the high-risk leukemia AMKL to check for genetic alterations that can help guide treatment.
DNA sequencing of bacteria leads to discovery of mutation that helps VRE tolerate antibiotics
Mystery sensor protein NLRC3 revealed as a central player in preventing colon cells from becoming cancerous
Research reveals principal tumor suppressor function of ARID1A and suggests that loss of the protein contributes to colon cancer
A possible targeted therapy is found for a high-risk form of acute lymphoblastic leukemia, the most common childhood cancer.
To improve patient safety, hospital leaders should provide feedback that demonstrates to staff the value of reporting safety events and errors.
Research from the Pediatric Cancer Genome Project identifies genomic landscape that contributes to the diversity of core-binding factor acute myeloid leukemia.
Explore more research news
More Research News
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Browse all scientific publications by St. Jude investigators in 2016.